Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07658937

Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients

Conditions: Health-Related Quality-of-Life, Cancer, Health Communication

Sex: All
Ages: 15 Years – 25 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Connecticut Children's Medical Center

Location: Children's Hospital Los Angeles Los Angeles California

Summary

The goal of this clinical trial is to learn if ReSPECT, which includes a pre-visit checklist for patients to complete and an informational website, can work well in practice to help adolescent and young adult oncology patients communicate with their clinicians about sexual and reproductive health (SRH). SRH includes topics such as how cancer may impact puberty and development, best methods for contraception during cancer treatment, fertility risk and fertility preservation strategies, and dating/relationships during and after cancer. The study will also help researchers better understand how to best measure the impact of ReSPECT on improving SRH communication for future testing of ReSPECT. The main questions the study aims to answer are: How well does ReSPECT work in practice? Do patients and clinicians like ReSPECT, and do they find it helpful? What are the best ways to test ReSPECT and measure whether it works? Participants will: Use ReSPECT to support a conversation about SRH during an outpatient oncology clinic appointment Complete surveys before and after using ReSPECT Provide feedback on their experience using ReSPECT in a short interview

Eligibility Criteria

Inclusion Criteria: * Age 15-25 years old * Has a cancer diagnosis * ≥2 months from diagnosis/initiation of therapy, whichever occurred later * Currently on cancer-directed therapy * Speaks and reads English * Approval from primary oncology team * Study participation by primary oncology clinician Exclusion Criteria: * Not able to provide informed consent/assent * Insufficient cognitive functioning to complete study measures, as determined by a member of the patient's primary oncology team * Exceeds primary oncologist's participant limit (3 patients/clinician)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07658937). StuddyBuddy aggregates publicly available trial information.